Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial assessing BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk; results completed…
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial evaluating BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk; study completed …
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
Phase 3 trial evaluating BF-200 ALA (Ameluz) with photodynamic therapy for actinic keratosis on extremities and neck/trunk completed.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of tirbanibulin ointment for actinic keratosis in adults completed.
-
EMA approval · 2026-06-03EMA Authorised: Ameluz (5-aminolevulinic acid hydrochloride) — Biofrontera Bioscience GmbH
EMA authorised Ameluz (5-aminolevulinic acid hydrochloride) for actinic keratosis and basal cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities [Phase 3]
A Phase 3 clinical trial evaluating reformulated Levulan Kerastick Plus PDT for actinic keratosis on the upper extremities is currently recr…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum [Phase 1]
An ongoing Phase 1 clinical trial is evaluating the safety of a topical regimen combining 5-fluorouracil with aluminum for actinic keratosis…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp [Phase 3]
This document notes a Phase 3 clinical trial evaluating a reformulated Levulan Kerastick plus photodynamic therapy for actinic keratosis on …
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy [NA]
A completed clinical trial evaluating the FLEXITHERALIGHT device versus conventional photodynamic therapy for actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses [Phase 3]
A Phase 3 pilot clinical trial is evaluating topical fluorouracil alone versus fluorouracil combined with calcipotriene for actinic keratosi…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Phase 2 Study of HW211026 in Participants With Actinic Keratosis [Phase 2]
A Phase 2 clinical trial of HW211026 for actinic keratosis is registered, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]
A Phase 3 study to evaluate the safety, tolerability, and efficacy of Ameluz (BF-200 ALA) for field-directed photodynamic therapy of actinic…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients [EARLY_Phase 1]
A randomized controlled trial evaluating topical 5% niacinamide for prevention of skin cancer in organ transplant recipients is in early pha…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis [Phase 3]
Phase 3 study evaluating the efficacy and safety of tirbanibulin ointment in adults with actinic keratosis has completed.
-
EMA approval · 2026-02-20EMA Authorised: Ameluz (5-aminolevulinic acid hydrochloride) — Biofrontera Bioscience GmbH
EMA authorized Ameluz (5-aminolevulinic acid hydrochloride) by Biofrontera Bioscience for actinic keratosis and basal cell carcinoma, markin…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses [Phase 2]
Phase 2 clinical trial completed evaluating imaging methods to monitor photosensitizer distribution and tissue oxygenation during photodynam…
-
EMA approval · 2026-02-19EMA Authorised: Klisyri (tirbanibulin) — Almirall, S.A.
The European Medicines Agency authorised Klisyri (tirbanibulin) for actinic keratosis.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Trial to Investigate GZ21T in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating GZ21T in healthy volunteers has completed, with results posted.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Evaluate RLS-1496 Topical Cream for Actinic Keratosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a topical cream called RLS-1496 for actinic keratosis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses [NA]
This clinical trial is evaluating a photoprotection product, Anthelios Fluide 100 KA+ UVMune 400, for prevention of actinic damage. The stud…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. [Phase 1]
A Phase Ib study of HW211026 ointment for actinic keratosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage [Phase 1]
This update reports the completion of a Phase 1 study evaluating Ameluz in combination with the BBL HEROic device for actinic keratosis and …
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans [Phase 2]
A Phase 2 trial is evaluating whether topical imipramine can influence photodynamic therapy-mediated immunosuppression in actinic keratosis …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK [NA]
Completed trial comparing 1-hour versus 2-hour illumination in indoor daylight photodynamic therapy for scalp actinic keratosis to evaluate …
-
CLINICAL_TRIALS other · 2025-12-09Clinical Trial Update: Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead [Phase 3]
Phase 3 trial evaluating cryotherapy followed by tirbanibulin ointment for actinic keratosis on the scalp and forehead; the study is not yet…